Helix Health and First Databank Partner to Provide Ireland's Leading Advanced Pharmacy Solutions

First DatabankFirst Databank (FDB), the UK's leading provider of drug knowledge bases and clinical decision support, today announced the continuation of the successful partnership with Helix Health. The contract provides Helix Health with FDB's trusted clinical databases for the next three years. Helix Health is continuing to use FDB's information within their product suite in the Republic of Ireland and UK, targeted towards hospital pharmacies and other healthcare sites. FDB's drug knowledge forms a core part of Helix Health's QicScript product range which is tailored to the community pharmacies both in the UK and Republic of Ireland.

Crevan O'Malley, group commercial manager at Helix Health explains why they decided to extend the contract; "We have dealt with First Databank for over 10 years, and they have provided us with an unfailing, high-calibre service over this period. Our customers rely on our products and services and First Databank's clinical databases form a core component to our offer. First Databank is a trusted partner of ours."

FDB's drug knowledge continues to be used within leading healthcare system vendors, hospitals and other healthcare organisations around the globe. Helix Health's product suites are trusted by over 80% of Irish hospitals and nearly 70% of Irish community pharmacies. The combination of the two companies' product strengths, provide reliable and quality solutions for Helix Health's customers. FDB's drug knowledge is featured within the QicScript product range delivering information on more than 10,000 pharmaceutical products to Helix Health's customers. Helix Health's QicScript.net product is a dispensary management system which helps pharmacists to deliver efficient, safe and cost-effective patient services. With advanced clinical support, QicScript.net allows the user to record detailed patient notes. First Databank's drug knowledge provides users with immediate access to comprehensive electronic drug information at the point-of-care which has a number of documented benefits including reduction of medication errors; reduction of costs associated with medication related harm, improved patient care, and improved efficiencies in workflow.

Darren Nichols, managing director at First Databank commented on the contract; "We are delighted that Helix Health has decided to extend their long-standing contract with us. It is testimony to our brilliant team here who provide ongoing support and clinical knowledge to support the Helix Health product range. First Databank's solutions provide clients with access to a depth and breadth of medicines information that is unmatched by any other provider and we are constantly working to develop and enhance our products to meet the market's needs. Long-standing business relationships, like this, only help to develop stronger, more innovative solutions to the market."

The partnership between FDB and Helix Health will ensure the continued development of innovative solutions and delivery of first-class services to customers in the Republic of Ireland and the UK.

Related news articles:

About First DataBank
First DataBank is the UK's leading provider of drug knowledge bases and active clinical decision support. With over 30 years' experience of maintaining, developing and integrating drug knowledge bases across the entire healthcare spectrum, First DataBank has unrivalled expertise and knowledge in this specialist field. NHS Connecting for Health has chosen First DataBank to provide drug-related clinical decision support.

Patient safety is the driving force behind our business. Through the effective integration of our products into clinical systems, we enable safer prescribing, dispensing and administration.

Our Multilex Drug Data File - the UK's most comprehensive and widely used drug knowledge base - is in daily use by thousands of healthcare professionals in the UK.

For further information visit www.firstdatabank.co.uk.

Most Popular Now

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...